Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RPID

RPID - Rapid Micro Biosystems, Inc. Stock Price, Fair Value and News

$4.62+0.37 (+8.71%)
Market Closed

20/100

RPID

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

20/100

RPID

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.3

Target 3M

$3.71

Target 6M

$3.5

RPID Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RPID Price Action

Last 7 days

0.2%

Last 30 days

59.3%

Last 90 days

58.8%

Trailing 12 Months

175%

RPID RSI Chart

RPID Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RPID Valuation

Market Cap

207.7M

Price/Earnings (Trailing)

-4.69

Price/Sales (Trailing)

6.8

EV/EBITDA

-1.86

Price/Free Cashflow

-5.38

RPID Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.3

Target 3M

$3.71

Target 6M

$3.5

RPID Fundamentals

RPID Revenue

Revenue (TTM)

30.5M

Rev. Growth (Yr)

3.08%

Rev. Growth (Qtr)

7.93%

RPID Earnings

Earnings (TTM)

-44.3M

Earnings Growth (Yr)

-1.61%

Earnings Growth (Qtr)

2.98%

RPID Profitability

EBT Margin

-223.27%

Return on Equity

-99.91%

Return on Assets

-52.47%

Free Cashflow Yield

-18.58%

RPID Investor Care

Shares Dilution (1Y)

3.32%

Diluted EPS (TTM)

-1.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202529.6M30.3M30.5M0
202423.1M24.7M26.2M28.1M
202318.0M19.1M20.6M22.5M
202222.4M20.1M18.0M17.1M
202117.9M19.7M21.4M23.2M
202000016.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Rapid Micro Biosystems, Inc.

RPID
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
 CEO
 WEBSITErapidmicrobio.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES177

Rapid Micro Biosystems, Inc. Frequently Asked Questions

RPID is the stock ticker symbol of Rapid Micro Biosystems, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Rapid Micro Biosystems, Inc. is 207.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RPID's fair value in chart for subscribers.

The fair value guage provides a quick view whether RPID is over valued or under valued. Whether Rapid Micro Biosystems, Inc. is cheap or expensive depends on the assumptions which impact Rapid Micro Biosystems, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RPID.

As of Wed Jan 28 2026, RPID's PE ratio (Price to Earnings) is -4.69 and Price to Sales (PS) ratio is 6.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RPID PE ratio will change depending on the future growth rate expectations of investors.